{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:37:23Z","timestamp":1792143443487,"version":"4.4.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["R21TR001718"],"award-info":[{"award-number":["R21TR001718"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s11095-019-2629-0","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T19:42:52Z","timestamp":1558122172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro"],"prefix":"10.1007","volume":"36","author":[{"given":"Thomas","family":"Lane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Anantpadma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Freundlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5790","authenticated-orcid":false,"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"2629_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/0471728780.ch1","volume-title":"Drug discovery handbook","author":"CB Spainhour","year":"2005","unstructured":"Spainhour CB. Naturla products. In: Gad SC, editor. Drug discovery handbook. Hoboken: John Wiley and Sons; 2005. p. 11\u201372."},{"issue":"3","key":"2629_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629\u201361.","journal-title":"J Nat Prod"},{"issue":"3","key":"2629_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"DJ Newman","year":"2012","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 2012;75(3):311\u201335.","journal-title":"J Nat Prod"},{"issue":"10","key":"2629_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7164\/antibiotics.28.721","volume":"28","author":"C Vezina","year":"1975","unstructured":"Vezina C, Kudelski A, Sehgal SN. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo). 1975;28(10):721\u20136.","journal-title":"J Antibiot (Tokyo)"},{"issue":"2","key":"2629_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I Chopra","year":"2001","unstructured":"Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232\u201360 second page, table of contents.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"2629_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/med.21359","volume":"36","author":"R Li","year":"2016","unstructured":"Li R. Marinopyrroles: unique drug discoveries based on marine natural products. Med Res Rev. 2016;36(1):169\u201389.","journal-title":"Med Res Rev"},{"issue":"6","key":"2629_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2010.02.005","volume":"31","author":"Alejandro M.S. Mayer","year":"2010","unstructured":"Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, et al. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci. 2010;31(6):255\u201365.","journal-title":"Trends in Pharmacological Sciences"},{"key":"2629_CR8","unstructured":"Kaiser R. Meaningful scents around the world. Zurich: Wiley, VCH; 2006."},{"issue":"2","key":"2629_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/08990220.2017.1299004","volume":"34","author":"T Tokunaga","year":"2017","unstructured":"Tokunaga T, Sugawara H, Tadano C, Muro M. Effect of stimulation of cold receptors with menthol on EMG activity of quadriceps muscle during low load contraction. Somatosens Mot Res. 2017;34(2):85\u201391.","journal-title":"Somatosens Mot Res"},{"key":"2629_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.micres.2016.12.008","volume":"197","author":"J Suchodolski","year":"2017","unstructured":"Suchodolski J, Feder-Kubis J, Krasowska A. Antifungal activity of ionic liquids based on (\u2212)-menthol: a mechanism study. Microbiol Res. 2017;197:56\u201364.","journal-title":"Microbiol Res"},{"key":"2629_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1423-0127-16-90","volume":"16","author":"R Wondergem","year":"2009","unstructured":"Wondergem R, Bartley JW. Menthol increases human glioblastoma intracellular Ca2+, BK channel activity and cell migration. J Biomed Sci. 2009;16:90.","journal-title":"J Biomed Sci"},{"issue":"2","key":"2629_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3164\/jcbn.08-201","volume":"44","author":"EJ Park","year":"2009","unstructured":"Park EJ, Kim SH, Kim BJ, Kim SY, So I, Jeon JH. Menthol enhances an Antiproliferative activity of 1alpha,25-Dihydroxyvitamin D(3) in LNCaP cells. J Clin Biochem Nutr. 2009;44(2):125\u201330.","journal-title":"J Clin Biochem Nutr"},{"issue":"1-3","key":"2629_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejphar.2008.06.003","volume":"590","author":"Erin E. Watt","year":"2008","unstructured":"Watt EE, Betts BA, Kotey FO, Humbert DJ, Griffith TN, Kelly EW, et al. Menthol shares general anesthetic activity and sites of action on the GABA(a) receptor with the intravenous agent, propofol. Eur J Pharmacol. 2008;590(1\u20133):120\u20136.","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"2629_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1179\/joc.2003.15.5.449","volume":"15","author":"AR Shahverdi","year":"2003","unstructured":"Shahverdi AR, Fazeli MR, Rafii F, Kakavand M, Jamalifar H, Hamedi J. Inhibition of nitrofurantoin reduction by menthol leads to enhanced antimicrobial activity. J Chemother. 2003;15(5):449\u201353.","journal-title":"J Chemother"},{"issue":"12","key":"2629_CR15","first-page":"539","volume":"3","author":"UR Juergens","year":"1998","unstructured":"Juergens UR, Stober M, Vetter H. The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. Eur J Med Res. 1998;3(12):539\u201345.","journal-title":"Eur J Med Res"},{"issue":"9","key":"2629_CR16","first-page":"1157","volume":"42","author":"M Zimmermann","year":"1992","unstructured":"Zimmermann M, Preac-Mursic V. In vitro activity of taurolidine, chlorophenol-camphor-menthol and chlorhexidine against oral pathogenic microorganisms. Arzneimittelforschung. 1992;42(9):1157\u20139.","journal-title":"Arzneimittelforschung."},{"key":"2629_CR17","unstructured":"CDC. 2014 ebola outbreak in West Africa - case counts 2016. Available from: http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/case-counts.html . Accessed 3 may 2019."},{"issue":"10","key":"2629_CR18","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1586\/14787210.2014.948848","volume":"12","author":"T Hoenen","year":"2014","unstructured":"Hoenen T, Feldmann H. Reverse genetics systems as tools for the development of novel therapies against filoviruses. Expert Rev Anti-Infect Ther. 2014;12(10):1253\u201363.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"190","key":"2629_CR19","doi-asserted-by":"publisher","first-page":"190ra79","DOI":"10.1126\/scitranslmed.3005471","volume":"5","author":"L. M. Johansen","year":"2013","unstructured":"Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, et al. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med. 2013;5(190):190ra179\u20139.","journal-title":"Science Translational Medicine"},{"issue":"4","key":"2629_CR20","doi-asserted-by":"publisher","first-page":"e60579","DOI":"10.1371\/journal.pone.0060579","volume":"8","author":"Peter B. Madrid","year":"2013","unstructured":"Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, Green CE, Iyer LV, Dilks HH, Davey RA, Kolokoltsov AA, Carrion R, Jr., Patterson JL, Bavari S, Panchal RG, Warren TK, Wells JB, Moos WH, Burke RL, Tanga MJ. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One 2013;8(4):e60579.","journal-title":"PLoS ONE"},{"issue":"290","key":"2629_CR21","doi-asserted-by":"publisher","first-page":"290ra89","DOI":"10.1126\/scitranslmed.aaa5597","volume":"7","author":"Lisa M. Johansen","year":"2015","unstructured":"Johansen LM, DeWald LE, Shoemaker CJ, Hoffstrom BG, Lear-Rooney CM, Stossel A, et al. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci Transl Med. 2015;7(290):290ra289.","journal-title":"Science Translational Medicine"},{"issue":"1","key":"2629_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2014.88","volume":"3","author":"Jennifer Kouznetsova","year":"2014","unstructured":"Kouznetsova J, Sun W, Martinez-Romero C, Tawa G, Shinn P, Chen CZ, et al. Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg Microbes Infect. 2014;3(12):e84.","journal-title":"Emerging Microbes & Infections"},{"issue":"8","key":"2629_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1021\/acsinfecdis.5b00053","volume":"1","author":"MR Edwards","year":"2015","unstructured":"Edwards MR, Pietzsch C, Vausselin T, Shaw ML, Bukreyev A, Basler CF. High-throughput Minigenome system for identifying small-molecule inhibitors of Ebola virus replication. ACS Infect Dis. 2015;1(8):380\u20137.","journal-title":"ACS Infect Dis"},{"issue":"19","key":"2629_CR24","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1128\/JVI.01337-15","volume":"89","author":"Han Cheng","year":"2015","unstructured":"Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, et al. Inhibition of Ebola and Marburg virus entry by G protein-coupled receptor antagonists. J Virol. 2015;89(19):9932\u20138.","journal-title":"Journal of Virology"},{"issue":"8","key":"2629_CR25","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1128\/AAC.00543-16","volume":"60","author":"Manu Anantpadma","year":"2016","unstructured":"Anantpadma M, Kouznetsova J, Wang H, Huang R, Kolokoltsov A, Guha R, et al. Large-scale screening and identification of novel Ebola virus and Marburg virus entry inhibitors. Antimicrob Agents Chemother. 2016;60(8):4471\u201381.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"2629_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2015.11.003","volume":"125","author":"Yizhuo Wang","year":"2016","unstructured":"Wang Y, Cui R, Li G, Gao Q, Yuan S, Altmeyer R, et al. Teicoplanin inhibits Ebola pseudovirus infection in cell culture. Antivir Res. 2016;125:1\u20137.","journal-title":"Antiviral Research"},{"key":"2629_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.antiviral.2017.12.019","volume":"150","author":"Priya Luthra","year":"2018","unstructured":"Luthra P, Liang J, Pietzsch CA, Khadka S, Edwards MR, Wei S, et al. A high throughput screen identifies benzoquinoline compounds as inhibitors of Ebola virus replication. Antivir Res. 2018;150:193\u2013201.","journal-title":"Antiviral Research"},{"key":"2629_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.12688\/f1000research.6120.1","volume":"4","author":"NK Litterman","year":"2015","unstructured":"Litterman NK, Lipinski CA, Ekins S. Small molecules with antiviral activity against the Ebola virus. F1000Res. 2015;4:38.","journal-title":"F1000Res."},{"key":"2629_CR29","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.drudis.2014.12.010","volume":"20","author":"E Picazo","year":"2014","unstructured":"Picazo E, Giordanetto F. Small molecule inhibitors of ebola virus infection. Drug Discov Today. 2014;20:277\u201386.","journal-title":"Drug Discov Today"},{"issue":"suppl 2","key":"2629_CR30","doi-asserted-by":"publisher","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","volume":"212","author":"Arnab Basu","year":"2015","unstructured":"Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, et al. Novel small molecule entry inhibitors of Ebola virus. J Infect Dis. 2015;212(Suppl 2):S425\u201334.","journal-title":"Journal of Infectious Diseases"},{"key":"2629_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12688\/f1000research.6085.1","volume":"4","author":"J Long","year":"2015","unstructured":"Long J, Wright E, Molesti E, Temperton N, Barclay W. Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Res. 2015;4:30.","journal-title":"F1000Res"},{"issue":"7364","key":"2629_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"Jan E. Carette","year":"2011","unstructured":"Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, et al. Ebola virus entry requires the cholesterol transporter Niemann-pick C1. Nature. 2011;477(7364):340\u20133.","journal-title":"Nature"},{"issue":"3","key":"2629_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40588-015-0021-3","volume":"2","author":"BA Rhein","year":"2015","unstructured":"Rhein BA, Maury WJ. Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Microbiol Rep. 2015;2(3):115\u201324.","journal-title":"Curr Clin Microbiol Rep"},{"key":"2629_CR34","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.12688\/f1000research.7217.2","volume":"4","author":"S Ekins","year":"2016","unstructured":"Ekins S, Freundlich JS, Clark AM, Anantpadma M, Davey RA. P. M. machine learning models identify molecules active against the Ebola virus in vitro. F1000Res. 2016;4:1091.","journal-title":"F1000Res."},{"key":"2629_CR35","doi-asserted-by":"crossref","unstructured":"Ekins S, Lingerfelt MA, Comer JE, Freiberg AN, Mirsalis JC, O\u2019Loughlin K, et al. Efficacy of Tilorone Dihydrochloride against Ebola virus infection. Antimicrob Agents Chemother. 2017;In Press;62.","DOI":"10.1128\/AAC.01711-17"},{"key":"2629_CR36","doi-asserted-by":"publisher","unstructured":"Bai JPF, Hsu CW. Drug repurposing for Ebola virus disease: principles of consideration and the animal rule. J Pharm Sci. 2018. https:\/\/doi.org\/10.1016\/j.xphs.2018.1009.1010 Epub ahead of print.","DOI":"10.1016\/j.xphs.2018.1009.1010"},{"issue":"4","key":"2629_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1086\/367544","volume":"36","author":"MF Murray","year":"2003","unstructured":"Murray MF. Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus. Clin Infect Dis. 2003;36(4):453\u201360.","journal-title":"Clin Infect Dis"},{"key":"2629_CR38","doi-asserted-by":"crossref","unstructured":"Andrade-Ochoa S, Nevarez-Moorillon GV, Sanchez-Torres LE, Villanueva-Garcia M, Sanchez-Ramirez BE, Rodriguez-Valdez LM, et al. Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium bovis. BMC Complement Altern Med. 2015;15:332.","DOI":"10.1186\/s12906-015-0858-2"},{"issue":"3","key":"2629_CR39","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00705-015-2712-8","volume":"161","author":"Wan-Yu Li","year":"2015","unstructured":"Li WY, Ren JH, Tao NN, Ran LK, Chen X, Zhou HZ, et al. The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo. Arch Virol. 2016;161(3):621\u201330.","journal-title":"Archives of Virology"},{"key":"2629_CR40","doi-asserted-by":"crossref","unstructured":"Sneader W. Drug discovery a history. Cheppenham: Wiley; 2005.","DOI":"10.1002\/0470015535"},{"issue":"10","key":"2629_CR41","doi-asserted-by":"publisher","first-page":"e78085","DOI":"10.1371\/journal.pone.0078085","volume":"8","author":"Fidele Ntie-Kang","year":"2013","unstructured":"Ntie-Kang F, Zofou D, Babiaka SB, Meudom R, Scharfe M, Lifongo LL, et al. AfroDb: a select highly potent and diverse natural product library from African medicinal plants. PLoS One. 2013;8(10):e78085.","journal-title":"PLoS ONE"},{"issue":"6","key":"2629_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4315\/0362-028X.JFP-15-593","volume":"79","author":"HAMADA A. ABOUBAKR","year":"2016","unstructured":"Aboubakr HA, Nauertz A, Luong NT, Agrawal S, El-Sohaimy SA, Youssef MM, et al. In vitro antiviral activity of clove and ginger aqueous extracts against feline Calicivirus, a surrogate for human norovirus. J Food Prot. 2016;79(6):1001\u201312.","journal-title":"Journal of Food Protection"},{"issue":"3","key":"2629_CR43","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.nbt.2016.01.001","volume":"33","author":"Wei-Jie Sun","year":"2016","unstructured":"Sun WJ, Lv WJ, Li LN, Yin G, Hang X, Xue Y, et al. Eugenol confers resistance to tomato yellow leaf curl virus (TYLCV) by regulating the expression of SlPer1 in tomato plants. New Biotechnol. 2016;33(3):345\u201354.","journal-title":"New Biotechnology"},{"issue":"4","key":"2629_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jsfa.6304","volume":"94","author":"C Wang","year":"2014","unstructured":"Wang C, Fan Y. Eugenol enhances the resistance of tomato against tomato yellow leaf curl virus. J Sci Food Agric. 2014;94(4):677\u201382.","journal-title":"J Sci Food Agric"},{"issue":"4","key":"2629_CR45","doi-asserted-by":"publisher","first-page":"e61026","DOI":"10.1371\/journal.pone.0061026","volume":"8","author":"Jian-Ping Dai","year":"2013","unstructured":"Dai JP, Zhao XF, Zeng J, Wan QY, Yang JC, Li WZ, et al. Drug screening for autophagy inhibitors based on the dissociation of Beclin1-Bcl2 complex using BiFC technique and mechanism of eugenol on anti-influenza a virus activity. PLoS One. 2013;8(4):e61026.","journal-title":"PLoS ONE"},{"key":"2629_CR46","doi-asserted-by":"publisher","first-page":"253643","DOI":"10.1093\/ecam\/nep187","volume":"2011","author":"A Astani","year":"2011","unstructured":"Astani A, Reichling J, Schnitzler P. Screening for antiviral activities of isolated compounds from essential oils. Evid Based Complement Alternat Med. 2011;2011:253643.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"2629_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/1099-1573(200011)14:7<495::AID-PTR650>3.0.CO;2-8","volume":"14","author":"F Benencia","year":"2000","unstructured":"Benencia F, Courreges MC. In vitro and in vivo activity of eugenol on human herpesvirus. Phytother Res. 2000;14(7):495\u2013500.","journal-title":"Phytother Res"},{"issue":"3","key":"2629_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0166-3542(99)00020-0","volume":"42","author":"KZ Bourne","year":"1999","unstructured":"Bourne KZ, Bourne N, Reising SF, Stanberry LR. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antivir Res. 1999;42(3):219\u201326.","journal-title":"Antivir Res"},{"issue":"12","key":"2629_CR49","doi-asserted-by":"publisher","first-page":"e0168815","DOI":"10.1371\/journal.pone.0168815","volume":"11","author":"N Turgeon","year":"2016","unstructured":"Turgeon N, Michel K, Ha TL, Robine E, Moineau S, Duchaine C. Resistance of aerosolized bacterial viruses to four germicidal products. PLoS One. 2016;11(12):e0168815.","journal-title":"PLoS One"},{"issue":"11","key":"2629_CR50","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/ps.3488","volume":"69","author":"SK Pandey","year":"2013","unstructured":"Pandey SK, Tandon S, Ahmad A, Singh AK, Tripathi AK. Structure-activity relationships of monoterpenes and acetyl derivatives against Aedes aegypti (Diptera: Culicidae) larvae. Pest Manag Sci. 2013;69(11):1235\u20138.","journal-title":"Pest Manag Sci"},{"issue":"6","key":"2629_CR51","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1080\/1040841X.2017.1295225","volume":"43","author":"Anna Marchese","year":"2017","unstructured":"Marchese A, Barbieri R, Coppo E, Orhan IE, Daglia M, Nabavi SF, et al. Antimicrobial activity of eugenol and essential oils containing eugenol: a mechanistic viewpoint. Crit Rev Microbiol. 2017;43(6):668\u201389.","journal-title":"Critical Reviews in Microbiology"},{"issue":"1","key":"2629_CR52","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12906-018-2392-5","volume":"18","author":"ML Abdullah","year":"2018","unstructured":"Abdullah ML, Hafez MM, Al-Hoshani A, Al-Shabanah O. Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells. BMC Complement Altern Med. 2018;18(1):321.","journal-title":"BMC Complement Altern Med"},{"key":"2629_CR53","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.fct.2018.07.050","volume":"120","author":"JL Bolton","year":"2018","unstructured":"Bolton JL, Dunlap TL, Dietz BM. Formation and biological targets of botanical o-quinones. Food Chem Toxicol. 2018;120:700\u20137.","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"2629_CR54","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.sbi.2010.04.003","volume":"20","author":"CW Murray","year":"2010","unstructured":"Murray CW, Blundell TL. Structural biology in fragment-based drug design. Curr Opin Struct Biol. 2010;20(4):497\u2013507.","journal-title":"Curr Opin Struct Biol"},{"issue":"14","key":"2629_CR55","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1021\/jm040031v","volume":"47","author":"DA Erlanson","year":"2004","unstructured":"Erlanson DA, McDowell RS, O'Brien T. Fragment-based drug discovery. J Med Chem. 2004;47(14):3463\u201382.","journal-title":"J Med Chem"},{"issue":"5\u20136","key":"2629_CR56","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.drudis.2008.11.007","volume":"14","author":"SD Bembenek","year":"2009","unstructured":"Bembenek SD, Tounge BA, Reynolds CH. Ligand efficiency and fragment-based drug discovery. Drug Discov Today. 2009;14(5\u20136):278\u201383.","journal-title":"Drug Discov Today"},{"issue":"1","key":"2629_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/jme\/tjx183","volume":"55","author":"AT Showler","year":"2018","unstructured":"Showler AT, Harlien JL. Effects of the botanical compound p-Anisaldehyde on horn Fly (Diptera: Muscidae) repellency, mortality, and reproduction. J Med Entomol. 2018;55(1):183\u201392.","journal-title":"J Med Entomol"},{"issue":"1","key":"2629_CR58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jme\/tjx158","volume":"55","author":"AT Showler","year":"2018","unstructured":"Showler AT, Harlien JL. Botanical compound p-Anisaldehyde repels larval lone star tick (Acari: Ixodidae), and halts reproduction by gravid adults. J Med Entomol. 2018;55(1):200\u20139.","journal-title":"J Med Entomol"},{"issue":"4","key":"2629_CR59","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ps.3411","volume":"69","author":"QH Zhang","year":"2013","unstructured":"Zhang QH, Schneidmiller RG, Hoover DR. Essential oils and their compositions as spatial repellents for pestiferous social wasps. Pest Manag Sci. 2013;69(4):542\u201352.","journal-title":"Pest Manag Sci"},{"issue":"9","key":"2629_CR60","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s10886-009-9683-8","volume":"35","author":"JA Swanson","year":"2009","unstructured":"Swanson JA, Torto B, Kells SA, Mesce KA, Tumlinson JH, Spivak M. Odorants that induce hygienic behavior in honeybees: identification of volatile compounds in chalkbrood-infected honeybee larvae. J Chem Ecol. 2009;35(9):1108\u201316.","journal-title":"J Chem Ecol"},{"issue":"3","key":"2629_CR61","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/acsinfecdis.6b00209","volume":"3","author":"Gai Liu","year":"2017","unstructured":"Liu G, Nash PJ, Johnson B, Pietzsch C, Ilagan MX, Bukreyev A, et al. A sensitive in vitro high-throughput screen to identify Pan-filoviral replication inhibitors targeting the VP35-NP Interface. ACS Infect Dis. 2017;(3, 3):190\u20138.","journal-title":"ACS Infectious Diseases"},{"issue":"1","key":"2629_CR62","first-page":"1","volume":"26","author":"WC Reeves","year":"2001","unstructured":"Reeves WC. Partners: serendipity in arbovirus research. J Vector Ecol. 2001;26(1):1\u20136.","journal-title":"J Vector Ecol"},{"issue":"1","key":"2629_CR63","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0959-8049(00)00379-8","volume":"37","author":"JF Smyth","year":"2001","unstructured":"Smyth JF. Science and serendipity in cancer research. Eur J Cancer. 2001;37(1):8.","journal-title":"Eur J Cancer"},{"issue":"2","key":"2629_CR64","first-page":"64","volume":"44","author":"J Duffin","year":"2002","unstructured":"Duffin J. Poisoning the spindle: serendipity and discovery of the anti-tumor properties of the Vinca alkaloids. Pharm Hist. 2002;44(2):64\u201376.","journal-title":"Pharm Hist"},{"issue":"22","key":"2629_CR65","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1021\/jm900340a","volume":"52","author":"Jialin Mao","year":"2009","unstructured":"Mao J, Yuan H, Wang Y, Wan B, Pieroni M, Huang Q, et al. From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters. J Med Chem. 2009;52(22):6966\u201378.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"10","key":"2629_CR66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3928\/02793695-20100903-01","volume":"48","author":"RH Howland","year":"2010","unstructured":"Howland RH. Serendipity and psychopharmacology. J Psychosoc Nurs Ment Health Serv. 2010;48(10):9\u201312.","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"issue":"6","key":"2629_CR67","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pharma.2011.10.001","volume":"69","author":"C Monneret","year":"2011","unstructured":"Monneret C. Platinum anticancer drugs. From serendipity to rational design. Ann Pharm Fr. 2011;69(6):286\u201395.","journal-title":"Ann Pharm Fr"},{"issue":"18","key":"2629_CR68","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2174\/15680266113136660164","volume":"13","author":"B Bolgar","year":"2013","unstructured":"Bolgar B, Arany A, Temesi G, Balogh B, Antal P, Matyus P. Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies. Curr Top Med Chem. 2013;13(18):2337\u201363.","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"2629_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-016-2039-5","volume":"34","author":"S Ekins","year":"2017","unstructured":"Ekins S, Diaz N, Chung J, Mathews P, McMurtray A. Enabling anyone to translate clinically relevant ideas to therapies. Pharm Res. 2017;34(1):1\u20136.","journal-title":"Pharm Res"},{"key":"2629_CR70","first-page":"16","volume-title":"High throughput screening methods: evolution and refinement","author":"DW Young","year":"2017","unstructured":"Young DW. Considerations related to small-molecule screening collections. In: Bittker JA, Ross NT, editors. High throughput screening methods: evolution and refinement. Cambridge: The Royal Society of Chemistry; 2017. p. 16\u201336."},{"issue":"44","key":"2629_CR71","doi-asserted-by":"publisher","first-page":"9275","DOI":"10.1039\/C7OB02193C","volume":"15","author":"T Rodrigues","year":"2017","unstructured":"Rodrigues T. Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point. Org Biomol Chem. 2017;15(44):9275\u201382.","journal-title":"Org Biomol Chem"},{"issue":"2","key":"2629_CR72","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/bib\/bbv042","volume":"17","author":"A Mohamed","year":"2016","unstructured":"Mohamed A, Nguyen CH, Mamitsuka H. Current status and prospects of computational resources for natural product dereplication: a review. Brief Bioinform. 2016;17(2):309\u201321.","journal-title":"Brief Bioinform"},{"issue":"2","key":"2629_CR73","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrd4510","volume":"14","author":"AL Harvey","year":"2015","unstructured":"Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111\u201329.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2629-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2629-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2629-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,13]],"date-time":"2020-12-13T10:26:53Z","timestamp":1607855213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2629-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2629"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2629-0","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"104"}}